相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Investigation of Suicidality and Psychological Adverse Events in Patients Treated With Finasteride
David-Dan Nguyen et al.
JAMA DERMATOLOGY (2021)
5α-Reductase Inhibitors and Risk of Prostate Cancer Death
Tiago Bonde Miranda et al.
JOURNAL OF UROLOGY (2020)
Long-Term Effects of Finasteride on Prostate Cancer Mortality
Phyllis J. Goodman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Association of Treatment With 5-Reductase Inhibitors With Time to Diagnosis and Mortality in Prostate Cancer
Reith R. Sarkar et al.
JAMA INTERNAL MEDICINE (2019)
A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Postfinasteride Syndrome
Wesley R. Baas et al.
UROLOGY (2018)
Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial
Joseph M. Unger et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink
Katrina Wilcox Hagberg et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink
Katrina Wilcox Hagberg et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial
Joseph M. Unger et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Projecting prostate cancer mortality in the PCPT and REDUCE chemoprevention trials
Paul F. Pinsky et al.
CANCER (2013)
Impact of 5-Alpha Reductase Inhibitors on Men Followed by Active Surveillance for Prostate Cancer: A Time-dependent Covariate Reanalysis
Lih-Ming Wong et al.
EUROPEAN UROLOGY (2013)
Long-Term Survival of Participants in the Prostate Cancer Prevention Trial
Ian M. Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Use of 5α-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control study
David Robinson et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer
Ashley E. Ross et al.
BJU INTERNATIONAL (2012)
The role of 5-alpha-reductase inhibitors in active surveillance
David Margel et al.
CURRENT OPINION IN UROLOGY (2012)
Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial
Neil E. Fleshner et al.
LANCET (2012)
Smoking and Prostate Cancer Survival and Recurrence
Stacey A. Kenfield et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Coffee Consumption and Prostate Cancer Risk and Progression in the Health Professionals Follow-up Study
Kathryn M. Wilson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention
Marc R. Theoret et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Reduced Levels of 5-α Reductase 2 in Adult Prostate Tissue and Implications for BPH Therapy
Yinong Niu et al.
PROSTATE (2011)
A Novel Two-Stage, Transdisciplinary Study Identifies Digoxin as a Possible Drug for Prostate Cancer Treatment
Elizabeth A. Platz et al.
CANCER DISCOVERY (2011)
Knowledge and Use of Finasteride for the Prevention of Prostate Cancer
Robert J. Hamilton et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Effect of Dutasteride on the Risk of Prostate Cancer.
Gerald L. Andriole et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Prostate cancer: a serious disease suitable for prevention
John M. Fitzpatrick et al.
BJU INTERNATIONAL (2009)
Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study
Jocelyn S. Kasper et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Pathologic Characteristics of Cancers Detected in the Prostate Cancer Prevention Trial: Implications for Prostate Cancer Detection and Chemoprevention
M. Scott Lucia et al.
CANCER PREVENTION RESEARCH (2008)
Type 1 and type 2 5α-reductase expression in the development and progression of prostate cancer
Lynn N. Thomas et al.
EUROPEAN UROLOGY (2008)
Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection
Ian M. Thompson et al.
JOURNAL OF UROLOGY (2007)
Statin drugs and risk of advanced prostate cancer
Elizabeth A. Platz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia
JD McConnell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The influence of finasteride on the development of prostate cancer
IM Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
